Tubular and Interstitial Cell Apoptosis in the Streptozotocin-Diabetic Rat KidneyKumar D.c · Zimpelmann J.c · Robertson S.b · Burns K.D.a,c
aDivision of Nephrology, Department of Medicine, and bDepartment of Laboratory Medicine, The Ottawa Hospital, Ottawa, Ont.; cKidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ont., Canada
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background/Aims: Angiotensin II (Ang II) mediates progressive nephron loss in diabetes and stimulates apoptotic cell death in several tissues. We studied the extent of apoptosis in streptozotocin (STZ) induced diabetic nephropathy in the rat and the effects of insulin and type 1 (AT1) or type 2 (AT2) Ang II receptor blockade with losartan or PD123319, respectively. Methods: Three groups of rats were studied after 2 and 12 weeks: (1) controls ; (2) STZ-diabetic rats (STZ rats), and (3) STZ-diabetic rats with insulin implants. Additional rats were treated with losartan (25 mg/kg/day) and/or PD123319 (10 mg/kg/day) for 2 weeks. Kidneys were examined for apoptosis, using the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, DNA laddering, and electron microscopy. Immunoblotting determined expression of the proapoptotic protein Bax and of the antiapoptotic protein Bcl-2 in proximal tubules. Results: Diabetes caused a significant increase in apoptosis, involving tubular and interstitial cells of cortex and medulla, but not glomerular cells (2 weeks: controls 264 ± 94 vs. STZ rats 1,501 ± 471 apoptotic nuclei/kidney section; p < 0.02; n = 6–8), an effect reversed by insulin. In STZ rats, ultrastructural examination revealed chromatin condensation and nuclear fragmentation in tubular and interstitial cells. At 2 and 12 weeks, a significant decrease in the expression of the antiapoptotic protein Bcl-2 occurred in STZ rat proximal tubules, with restoration by insulin. In STZ rats, treatment for 2 weeks with losartan or PD123319 inhibited apoptosis in the kidneys, with no additive effect of the combination therapy. Conclusions: Apoptosis occurs in diabetic nephropathy, involving tubular and interstitial cells, an effect reversed by insulin therapy. Furthermore, the effects of AT1 or AT2 receptor blockade suggest that Ang II is involved in mediating apoptosis in the diabetic kidney.
© 2004 S. Karger AG, Basel
- Shimizu A, Kitamura H, Masuda Y, Ishizaki Y, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 1995;47:114–121.
- Ortiz A, Ziyadeh FN, Neilson EG: Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 1997;45:50–56.
- Daemen MA, van ‘t Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999;104:541–549.
Morrissey JJ, Klahr S: Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol 1999;276:F39–F45.
- Schelling JR, Cleveland RP: Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure. Kidney Int 1999;56:1313–1316.
- Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994;94:2105–2116.
- Sugiyama H, Kashihara N, Makino Y, Yamasaki Y, Ota A: Apoptosis in glomerular sclerosis. Kidney Int 1996;49:103–111.
- Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM: Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1998;4:1421–1424.
- Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhäusl W: High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995;44:1323–1327.
- Lorenzi M, Montisano DF, Toledo S, Barrieux A: High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest 1986;77:322–325.
- Donath MY, Gross DJ, Cerasi E, Kaiser N: Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 1999;48:738–744.
- Ishii N, Ogawa Z, Suzuki K, Numakami K, Saruta T, Itoh H: Glucose loading induces DNA fragmentation in rat proximal tubular cells. Metabolism 1996;45:1348–1353.
- Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW: Neural apoptosis in the retina during experimental and human diabetes: Early onset and effect of insulin. J Clin Invest 1998;102:783–791.
- Jonassen AK, Brar BK, Mjos OD, Sack MN, Latchman DS, Yellon DM: Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 2000;32:757–764.
- Remuzzi A, Perico N, Amuchastegui CS, Malanchini M, Mazerska M, Battaglia C, Bertani T, Remuzzi G: Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 1993;4:40–49.
- Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456–1462.
- Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM: Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1997;30:1238–1246.
Chevalier RL, Thornhill BA, Wolstenholme JT: Renal cellular response to ureteral obstruction: Role of maturation and angiotensin II. Am J Physiol 1999;277:F41–F47.
- Lehtonen JY, Horiuchi M, Daviet L, Akishita M, Dzau VJ: Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. J Biol Chem 1999;274:16901–16906.
- Yamada T, Horiuchi M, Dzau VJ: Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A 1996;93:156–160.
- Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P: Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997;29:859–870.
- Cigola E, Kajstura J, Li B, Meggs LG, Anversa P: Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res 1997;231:363–371.
- Sharma SK, Chapman D, Temsah R, Netticadan T, Brasil DP, Dhalla NS: Prevention of vascular apoptosis in myocardial infarction by losartan. J Cardiovasc Pharmacol Ther 1999;4:77–84.
- Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J: Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab Invest 2000;80:513–527.
- Kelly DJ, Cox AJ, Tolcos M, Cooper ME, Wilkinson-Berker TL, Gilbert RE: Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 2002;61:31–39.
Kontogiannis J, Burns KD: Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 1998;274:F79–F90.
Komers R, Cooper ME: Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: Role of kinins. Am J Physiol 1995;268:F588–F594.
Zimpelmann J, Burns KD: Angiotensin II AT2 receptors inhibit growth responses in proximal tubule cells. Am J Physiol Renal Physiol 2001;281:F300–F308.
- Shankland SJ, Scholey JW: Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int 1995;47:782–788.
Ortiz A, Lorz C, Catalan MP, Justo P, Egido J: Role and regulation of apoptotic cell death in the kidney. Y2K update. Front Biosci 2000;5:D735–D749.
- Perlman H, Maillard L, Krasinski K, Walsh K: Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 1997;95:981–987.
- Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassman H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994;71:219–225.
- Kelly KJ: Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003;14:1549–1558.
Kumar D, Robertson S, Burns KD: Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem, in press.
- Murata M, Takahashi A, Saito I, Kawanishi S: Site-specific DNA methylation and apoptosis: Induction by diabetogenic streptozotocin. Biochem Pharmacol 1999;57:881–887.
Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC: Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 2003;284:F955–F965.
- Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, Kraemer FB, Hoffman AR, Schambelan M: The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. J Am Soc Nephrol 1993;4:1337–1345.
- Correa-Rotter R, Hostetter TH, Rosenberg ME: Renin and angiotensinogen gene expression in experimental diabetes mellitus. Kidney Int 1992;41:796–804.
- Ortiz A, Lorz C, Catalan MP, Danoff TM, Yamasaki Y, Egido J, Neilson EG: Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 2000;57:969–981.
Ortiz A, Lorz C, Catalan M, Coca S, Egido J: Cyclosporine A induces apoptosis in murine tubular epithelial cells: Role of caspases. Kidney Int Suppl 1998;68:S25–S29.
- Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM, Johnson RJ: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998;53:897–908.
- Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P: Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998;101:1326–1342.
- Fortuno MA, Ravassa S, Etayo JC, Diez J: Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: Effects of AT1 blockade with losartan. Hypertension 1998;32:280–286.
Wehbi GJ, Zimpelmann J, Carey RM, Levine DZ, Burns KD: Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors. Am J Physiol Renal Physiol 2001;280:F254–F265.
- Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I: Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 1999;53:937–944.
- Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ: Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 1997;272:19022–19026.
Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, Kasinath BS, Singhal PC: Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002;283:F173–F180.
- Wolf K, Castrop H, Hartner A, Goppelt-Strube M, Hilgers KF, Kurtz A: Inhibition of the renin-angiotensin system upregulates cyclooxygenase-2 expression in the macula densa. Hypertension 1999;34:503–507.
- Ardaillou R, Chansel D: Synthesis and effects of active fragments of angiotensin II. Kidney Int 1997;52:1458–1468.
Kakinuma Y, Hama H, Sugiyama F, Goto K, Murakami K, Fukamizu A: Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice. Neurosci Lett 1997;232:167–170.
- Amiri F, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB: Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells. J Biol Chem 1999;274:32382–32386.
- Hadad SJ, Ferreira AT, Oshiro ME, Neri R, Schor N: Alteration of cytosolic calcium induced by angiotensin II and norepinephrine in mesangial cells from diabetic rats. Kidney Int 1997;51:87–93.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.